Medical/Pharmaceuticals

Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children

* In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypesleading to most of the invasive pneumococcal diseases and pneumonia[i],[ii] – is now approved fo...

2024-12-03 15:08 1793

Fosun's Rural Doctors Program Recognized in UNGC's "20 Cases of Private Sector's Sustainable Development in China for 20 Years" Report

HONG KONG, Dec. 3, 2024 /PRNewswire/ -- This year marks the 20th anniversary of the United Nations Global Compact ("UNGC")'s introduction of Environmental, Social, and Governance (ESG) concept and principles. On29 November 2024, the UNGC held a launch event for the "20 Cases of Private Sector's S...

2024-12-03 11:47 1683

Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024

CHICAGO, Dec. 3, 2024 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical Systems"), a global leader in medical imaging solutions and services, is proud to announce its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting, taking place in Chicago fr...

2024-12-03 09:50 1627

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority

Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 3, 2024 /PRNewswire/ -- MatOrtho, the UK-based global innovator of hip and knee replacement devices, today announced that the ReCerf® Hip Resurfacing Arthroplasty has become the world's first all-ceramic hip ...

2024-12-03 00:08 1527

2024 Medtec Attracts Over 80,000 Industry Attendees, Helping China's Medical Device Sector Step into a New Era of Quality Development

SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- The 2024 Medtec and the 18th International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2024 Medtec), organized by Informa Markets, was successfully held at the Shanghai World Expo Exhibition and Convention Center ...

2024-12-02 23:00 1046

European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New Study on Bioregenerative Blueprint for Athletic Longevity

KOTA KINABALU, Malaysia, Dec. 2, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, has unveiled a groundbreaking study led by renowned expert Prof.Mike Chan on the physiological challenges aging athletes face. The analysis explores how age ...

2024-12-02 16:30 2375

Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong

SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Gover...

2024-12-02 07:40 1618

When ancient cures meet smart tech: Level up your health

BEIJING, Dec. 1, 2024 /PRNewswire/ -- This is a report from China.org.cn.   Join presenter Jason Dane Castleton at the Health and Wellness pavilion of the second China International Supply Chain Expo, where innovations from traditional medicine to genetic technology are transform...

2024-12-01 19:34 2353

CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

* CBC Group and Mubadala acquire UCB's mature neurology and allergy business inChina for US$680 million. * New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. * Strategic acquisition under CBC's buyout strategy exp...

2024-11-30 09:00 5527

"Are your Hands & Feet trying to tell you something?" - Ask leading Health Experts

* Do you feel numbness, pain, tingling or pins and needles in your hands and feet? * 8 out of 10 patients with Peripheral Neuropathy don't listen to what their nerves are telling them and go undiagnosed leading to worsening of symptoms. MANILA, Philippines, Nov. 29, 2024 /PRNewswire/ -- As pa...

2024-11-29 13:30 1772

Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore

SINGAPORE, Nov. 29, 2024 /PRNewswire/ -- Leading health and nutrition company, Borsch Med Pte Ltd (Borch Med) has announced that Zeria chrondroitin-based joint health supplements are now available at selected Unity pharmacies in Singapore. The enhanced distribution network of the Japanese-made sup...

2024-11-29 10:00 1721

Microbio Appoints Paul Brennan as Chair of the Board

BRISBANE, Australia, Nov. 29, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has appointedPaul Brennan as Chair of the Board, effective 2nd December 2024. Paul brings extensive global experience as a Non-E...

2024-11-29 06:30 1819

Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific...

2024-11-28 21:30 3036

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

MELBOURNE, Australia, Nov. 28, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) today announce that a first patient has been dosed in the Phase III ZIRCON-CP trial of TLX250-CDx positron ...

2024-11-28 17:22 2028

New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the new indication...

2024-11-28 16:59 2059

Own Your Story with AwarerHOME™

Malaysia's HIV Oral Self-Test for Accessible and Confident Testing KUALA LUMPUR, Malaysia, Nov. 28, 2024 /PRNewswire/ -- Say hello to confidence and control with AwarerHOME™,Malaysia's first homegrown HIV Oral Self-Test. This accessible, no-mess, no-fuss solution offers something even more impor...

2024-11-28 16:34 1532

Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List

SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that NEFECON® has been included in the...

2024-11-28 13:43 1750

Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country

SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hema...

2024-11-28 13:04 1866

Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-11-28 12:07 2146

Newbase Launches 'Medicrew', a VR Medical Training Platform to Accelerate Global Market Expansion

Participation in IMSH 2025 to Showcase Innovations in Medical Education SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- Newbase , a leader in metaverse-based medical education platforms, announced on the 28th the launch of its new product, 'Medicrew', a platform des...

2024-11-28 09:00 1621
1 ... 3456789 ... 398